Matt Wortham
@worthamlab.bsky.social
130 followers 98 following 17 posts
Assistant Professor at the Barbara Davis Center for Diabetes at University of Colorado Anschutz. The Wortham lab studies how nutrients govern adaptive and maladaptive responses by pancreatic beta cells in health and metabolic disease. www.worthamlab.org
Posts Media Videos Starter Packs
worthamlab.bsky.social
It's great to see the final version of our SIRT2 paper in JCI along with an astute commentary from trailblazers in beta cell regeneration—thanks for highlighting our work! @likatz.bsky.social @donaldscottmssm.bsky.social @jci.org @sanderlaberlin.bsky.social tinyurl.com/y6rx69x7 tinyurl.com/ydvv9u2s
Reposted by Matt Wortham
jeffreymillman.bsky.social
Join us for the 2025 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium. We have an amazing program this year focusing on type 1 #diabetes. We have also extended the abstract submission deadline to Sept 19. Register and submit your abstract a www.levinesymposium.com
worthamlab.bsky.social
Thanks for the kind words Scott!
worthamlab.bsky.social
Based on these preclinical studies, we consider SIRT2 a promising target for stimulating beta cell regeneration in diabetes. Thank you NIH & Breakthrough T1D for funding, @iidp.bsky.social for islets, and collaborators Orian Shirihai, Kristen Wells, @goniaguy4.bsky.social, & @auwerx-lab.bsky.social!
worthamlab.bsky.social
Mechanistically, SIRT2 deacetylates glycolytic and TCA enzymes, dampening islet oxygen consumption during hyperglycemia. In addition to its direct effect on metabolism, SIRT2 impacts how beta cells transcriptionally interpret hyperglycemia as a stress.
worthamlab.bsky.social
We show that inactivation of SIRT2 increases beta cell proliferation in mice when glucose is elevated above the physiological set point, indicating SIRT2 dampens adaptive beta cell proliferation. SIRT2 also restrains human beta cell proliferation but over a broader range of glucose concentrations.
worthamlab.bsky.social
First off, huge shoutout to co-first authors Bastian Ramms, Chun Zeng, and Jackie Benthuysen from Maike Sander’s lab, and to those who helped with revision experiments including my new colleagues at @cuanschutz.bsky.social @cudevbio.bsky.social
worthamlab.bsky.social
Out today in @jclinical-invest.bsky.social! We discovered a novel regulator of adaptive beta cell proliferation, the protein deacetylase SIRT2, that acts through a metabolic mechanism. Bluetorial below (1/5).
tinyurl.com/ydvv9u2s
JCI - The protein deacetylase SIRT2 exerts metabolic control over adaptive β cell proliferation
tinyurl.com
worthamlab.bsky.social
With credit to @huisinglab.bsky.social for inspiring the tradition, today we bid farewell to our very first lab member Sean Lee who is joining the Cell Biology, Stem Cells, and Development PhD program here at @cuanschutz.bsky.social‬. Best of luck Sean, we expect great things from you!
worthamlab.bsky.social
These are two important papers that profile beta cell excitotoxicity in response to a sulfonylurea or the VDAC1-stabilizing molecule SW016789. Comparing these studies should make for an excellent journal club. Congrats to all authors! @kalwat.bsky.social tinyurl.com/fwrzrtk9 tinyurl.com/3nzfsp79
VDAC1 is a target for pharmacologically induced insulin hypersecretion in β cells
β cells are dysfunctional in type 2 diabetes (T2D) and congenital hyperinsulinism (HI), but the mechanisms linking hypersecretion to β cell failure ar…
www.sciencedirect.com
Reposted by Matt Wortham
evgenykvon.bsky.social
How do non-coding variants in enhancers lead to disease? Happy to share our recent work, led by @ewholling.bsky.social, in which we discovered that poised chromatin sensitizes enhancers to aberrant activation by non-coding mutations, contributing to disease. www.biorxiv.org/content/10.1... 1/
Reposted by Matt Wortham
ardemp.bskyverified.social
Talked to @KateZernike at @nytimes about my journey and the current moment for scientists in the U.S.

“Ardem Patapoutian’s story is not just the American dream, it is the dream of American science.”

Read the article here. No subscription required:

www.nytimes.com/2025/06/03/u...
The U.S. Lit a Beacon for Science. Under Trump, Scientists Fear It’s Dimming
www.nytimes.com
Reposted by Matt Wortham
kalwat.bsky.social
Actin remodeling in beta cells adds new layers of upstream regulation - Congrats! @ronnyhelman.bsky.social
Reposted by Matt Wortham
aaronrcox.bsky.social
Check out my talk this afternoon where I’ll share our latest work! #isletbiology #metabolism #IMM The University of Texas Health Science Center at Houston (UTHealth Houston)
worthamlab.bsky.social
Our lab website www.worthamlab.org is now live! By the way, we are recruiting at all levels. If our work interests you, consider joining us for cutting edge research in a collegial environment at University of Colorado Anschutz. Not to mention that Denver is a great place to live.
Wortham Lab
www.worthamlab.org
Reposted by Matt Wortham
Reposted by Matt Wortham
danieljdrucker.bsky.social
Functional #insulin secretory defects occur in the remaining mass of beta cells during human #T1D pathogenesis not strictly correlated with the extent of insulitis #islets www.biorxiv.org/content/10.1...
Reposted by Matt Wortham
phillipjwhitephd.bsky.social
Abstracts for #METPHYS2025 are due this Friday!
There are multiple short talks available!

FEB28 is also the deadline for the Vanderbilt Vibrant program

This initiative will provide several awards of $2000 to help new investigators attend

www.sablesys.com/metphys2025-...
Reposted by Matt Wortham
bcellorg.bsky.social
We link molecular and functional phenotypes of islet cells from donors with type 1 diabetes to understand impaired insulin and glucagon secretion. Immune signalling, nuclear exclusion, mTOR and lysosomes in alpha cell dysfunction.

https://www.biorxiv.org/content/10.1101/2025.02.20.639325v1